The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Blood-based Biomarker Market

A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.

North American market for Blood-based Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood-based Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Blood-based Biomarker in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Blood-based Biomarker include Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Blood-based Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood-based Biomarker.

The Blood-based Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood-based Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood-based Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Blood-based Biomarker Market Report

Report Metric	Details
Report Name	Blood-based Biomarker Market
Accounted market size in year	US$ 1867 million
Forecasted market size in 2031	US$ 3638 million
CAGR	10.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Next Generation Sequencing Mass Spectrometry Liquid Biopsy Technologies
Segment by Application	Hospital Diagnostic Centers Research Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, Vernalis, Labcorp Drug Development
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood-based Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood-based Biomarker Market growing?

Ans: The Blood-based Biomarker Market witnessing a CAGR of 10.4% during the forecast period 2025-2031.

What is the Blood-based Biomarker Market size in 2031?

Ans: The Blood-based Biomarker Market size in 2031 will be US$ 3638 million.

Who are the main players in the Blood-based Biomarker Market report?

Ans: The main players in the Blood-based Biomarker Market are Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, Vernalis, Labcorp Drug Development

What are the Application segmentation covered in the Blood-based Biomarker Market report?

Ans: The Applications covered in the Blood-based Biomarker Market report are Hospital, Diagnostic Centers, Research Labs

What are the Type segmentation covered in the Blood-based Biomarker Market report?

Ans: The Types covered in the Blood-based Biomarker Market report are Next Generation Sequencing, Mass Spectrometry, Liquid Biopsy Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood-based Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Next Generation Sequencing

1.2.3 Mass Spectrometry

1.2.4 Liquid Biopsy Technologies

1.3 Market by Application

1.3.1 Global Blood-based Biomarker Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Diagnostic Centers

1.3.4 Research Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood-based Biomarker Market Perspective (2020-2031)

2.2 Global Blood-based Biomarker Growth Trends by Region

2.2.1 Global Blood-based Biomarker Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Blood-based Biomarker Historic Market Size by Region (2020-2025)

2.2.3 Blood-based Biomarker Forecasted Market Size by Region (2026-2031)

2.3 Blood-based Biomarker Market Dynamics

2.3.1 Blood-based Biomarker Industry Trends

2.3.2 Blood-based Biomarker Market Drivers

2.3.3 Blood-based Biomarker Market Challenges

2.3.4 Blood-based Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood-based Biomarker Players by Revenue

3.1.1 Global Top Blood-based Biomarker Players by Revenue (2020-2025)

3.1.2 Global Blood-based Biomarker Revenue Market Share by Players (2020-2025)

3.2 Global Top Blood-based Biomarker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Blood-based Biomarker Revenue

3.4 Global Blood-based Biomarker Market Concentration Ratio

3.4.1 Global Blood-based Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood-based Biomarker Revenue in 2024

3.5 Global Key Players of Blood-based Biomarker Head office and Area Served

3.6 Global Key Players of Blood-based Biomarker, Product and Application

3.7 Global Key Players of Blood-based Biomarker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood-based Biomarker Breakdown Data by Type

4.1 Global Blood-based Biomarker Historic Market Size by Type (2020-2025)

4.2 Global Blood-based Biomarker Forecasted Market Size by Type (2026-2031)

5 Blood-based Biomarker Breakdown Data by Application

5.1 Global Blood-based Biomarker Historic Market Size by Application (2020-2025)

5.2 Global Blood-based Biomarker Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Blood-based Biomarker Market Size (2020-2031)

6.2 North America Blood-based Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Blood-based Biomarker Market Size by Country (2020-2025)

6.4 North America Blood-based Biomarker Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood-based Biomarker Market Size (2020-2031)

7.2 Europe Blood-based Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Blood-based Biomarker Market Size by Country (2020-2025)

7.4 Europe Blood-based Biomarker Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Blood-based Biomarker Market Size (2020-2031)

8.2 Asia-Pacific Blood-based Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Blood-based Biomarker Market Size by Region (2020-2025)

8.4 Asia-Pacific Blood-based Biomarker Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Blood-based Biomarker Market Size (2020-2031)

9.2 Latin America Blood-based Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Blood-based Biomarker Market Size by Country (2020-2025)

9.4 Latin America Blood-based Biomarker Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood-based Biomarker Market Size (2020-2031)

10.2 Middle East & Africa Blood-based Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Blood-based Biomarker Market Size by Country (2020-2025)

10.4 Middle East & Africa Blood-based Biomarker Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Blood-based Biomarker Introduction

11.1.4 Roche Diagnostics Revenue in Blood-based Biomarker Business (2020-2025)

11.1.5 Roche Diagnostics Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Blood-based Biomarker Introduction

11.2.4 Thermo Fisher Scientific Revenue in Blood-based Biomarker Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Blood-based Biomarker Introduction

11.3.4 Bio-Rad Laboratories Revenue in Blood-based Biomarker Business (2020-2025)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Blood-based Biomarker Introduction

11.4.4 Qiagen Revenue in Blood-based Biomarker Business (2020-2025)

11.4.5 Qiagen Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Blood-based Biomarker Introduction

11.5.4 Abbott Revenue in Blood-based Biomarker Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 Siemens Healthineers

11.6.1 Siemens Healthineers Company Details

11.6.2 Siemens Healthineers Business Overview

11.6.3 Siemens Healthineers Blood-based Biomarker Introduction

11.6.4 Siemens Healthineers Revenue in Blood-based Biomarker Business (2020-2025)

11.6.5 Siemens Healthineers Recent Development

11.7 Danaher

11.7.1 Danaher Company Details

11.7.2 Danaher Business Overview

11.7.3 Danaher Blood-based Biomarker Introduction

11.7.4 Danaher Revenue in Blood-based Biomarker Business (2020-2025)

11.7.5 Danaher Recent Development

11.8 Quidel Corporation

11.8.1 Quidel Corporation Company Details

11.8.2 Quidel Corporation Business Overview

11.8.3 Quidel Corporation Blood-based Biomarker Introduction

11.8.4 Quidel Corporation Revenue in Blood-based Biomarker Business (2020-2025)

11.8.5 Quidel Corporation Recent Development

11.9 Grifols

11.9.1 Grifols Company Details

11.9.2 Grifols Business Overview

11.9.3 Grifols Blood-based Biomarker Introduction

11.9.4 Grifols Revenue in Blood-based Biomarker Business (2020-2025)

11.9.5 Grifols Recent Development

11.10 Biocartis

11.10.1 Biocartis Company Details

11.10.2 Biocartis Business Overview

11.10.3 Biocartis Blood-based Biomarker Introduction

11.10.4 Biocartis Revenue in Blood-based Biomarker Business (2020-2025)

11.10.5 Biocartis Recent Development

11.11 Vernalis

11.11.1 Vernalis Company Details

11.11.2 Vernalis Business Overview

11.11.3 Vernalis Blood-based Biomarker Introduction

11.11.4 Vernalis Revenue in Blood-based Biomarker Business (2020-2025)

11.11.5 Vernalis Recent Development

11.12 Labcorp Drug Development

11.12.1 Labcorp Drug Development Company Details

11.12.2 Labcorp Drug Development Business Overview

11.12.3 Labcorp Drug Development Blood-based Biomarker Introduction

11.12.4 Labcorp Drug Development Revenue in Blood-based Biomarker Business (2020-2025)

11.12.5 Labcorp Drug Development Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche Diagnostics

Thermo Fisher Scientific

Labcorp Drug Development

List of Tables

Table 1. Global Blood-based Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Next Generation Sequencing

Table 3. Key Players of Mass Spectrometry

Table 4. Key Players of Liquid Biopsy Technologies

Table 5. Global Blood-based Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Blood-based Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Blood-based Biomarker Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Blood-based Biomarker Market Share by Region (2020-2025)

Table 9. Global Blood-based Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Blood-based Biomarker Market Share by Region (2026-2031)

Table 11. Blood-based Biomarker Market Trends

Table 12. Blood-based Biomarker Market Drivers

Table 13. Blood-based Biomarker Market Challenges

Table 14. Blood-based Biomarker Market Restraints

Table 15. Global Blood-based Biomarker Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Blood-based Biomarker Market Share by Players (2020-2025)

Table 17. Global Top Blood-based Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-based Biomarker as of 2024)

Table 18. Ranking of Global Top Blood-based Biomarker Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Blood-based Biomarker Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Blood-based Biomarker, Headquarters and Area Served

Table 21. Global Key Players of Blood-based Biomarker, Product and Application

Table 22. Global Key Players of Blood-based Biomarker, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Blood-based Biomarker Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Blood-based Biomarker Revenue Market Share by Type (2020-2025)

Table 26. Global Blood-based Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Blood-based Biomarker Revenue Market Share by Type (2026-2031)

Table 28. Global Blood-based Biomarker Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Blood-based Biomarker Revenue Market Share by Application (2020-2025)

Table 30. Global Blood-based Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Blood-based Biomarker Revenue Market Share by Application (2026-2031)

Table 32. North America Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Blood-based Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Blood-based Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Blood-based Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Blood-based Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Blood-based Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Blood-based Biomarker Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Blood-based Biomarker Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Blood-based Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Blood-based Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Blood-based Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Blood-based Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Diagnostics Company Details

Table 48. Roche Diagnostics Business Overview

Table 49. Roche Diagnostics Blood-based Biomarker Product

Table 50. Roche Diagnostics Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 51. Roche Diagnostics Recent Development

Table 52. Thermo Fisher Scientific Company Details

Table 53. Thermo Fisher Scientific Business Overview

Table 54. Thermo Fisher Scientific Blood-based Biomarker Product

Table 55. Thermo Fisher Scientific Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific Recent Development

Table 57. Bio-Rad Laboratories Company Details

Table 58. Bio-Rad Laboratories Business Overview

Table 59. Bio-Rad Laboratories Blood-based Biomarker Product

Table 60. Bio-Rad Laboratories Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 61. Bio-Rad Laboratories Recent Development

Table 62. Qiagen Company Details

Table 63. Qiagen Business Overview

Table 64. Qiagen Blood-based Biomarker Product

Table 65. Qiagen Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 66. Qiagen Recent Development

Table 67. Abbott Company Details

Table 68. Abbott Business Overview

Table 69. Abbott Blood-based Biomarker Product

Table 70. Abbott Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 71. Abbott Recent Development

Table 72. Siemens Healthineers Company Details

Table 73. Siemens Healthineers Business Overview

Table 74. Siemens Healthineers Blood-based Biomarker Product

Table 75. Siemens Healthineers Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 76. Siemens Healthineers Recent Development

Table 77. Danaher Company Details

Table 78. Danaher Business Overview

Table 79. Danaher Blood-based Biomarker Product

Table 80. Danaher Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 81. Danaher Recent Development

Table 82. Quidel Corporation Company Details

Table 83. Quidel Corporation Business Overview

Table 84. Quidel Corporation Blood-based Biomarker Product

Table 85. Quidel Corporation Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 86. Quidel Corporation Recent Development

Table 87. Grifols Company Details

Table 88. Grifols Business Overview

Table 89. Grifols Blood-based Biomarker Product

Table 90. Grifols Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 91. Grifols Recent Development

Table 92. Biocartis Company Details

Table 93. Biocartis Business Overview

Table 94. Biocartis Blood-based Biomarker Product

Table 95. Biocartis Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 96. Biocartis Recent Development

Table 97. Vernalis Company Details

Table 98. Vernalis Business Overview

Table 99. Vernalis Blood-based Biomarker Product

Table 100. Vernalis Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 101. Vernalis Recent Development

Table 102. Labcorp Drug Development Company Details

Table 103. Labcorp Drug Development Business Overview

Table 104. Labcorp Drug Development Blood-based Biomarker Product

Table 105. Labcorp Drug Development Revenue in Blood-based Biomarker Business (2020-2025) & (US$ Million)

Table 106. Labcorp Drug Development Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Blood-based Biomarker Picture

Figure 2. Global Blood-based Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood-based Biomarker Market Share by Type: 2024 VS 2031

Figure 4. Next Generation Sequencing Features

Figure 5. Mass Spectrometry Features

Figure 6. Liquid Biopsy Technologies Features

Figure 7. Global Blood-based Biomarker Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Blood-based Biomarker Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Diagnostic Centers Case Studies

Figure 11. Research Labs Case Studies

Figure 12. Blood-based Biomarker Report Years Considered

Figure 13. Global Blood-based Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Blood-based Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Blood-based Biomarker Market Share by Region: 2024 VS 2031

Figure 16. Global Blood-based Biomarker Market Share by Players in 2024

Figure 17. Global Blood-based Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Blood-based Biomarker Revenue in 2024

Figure 19. North America Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Blood-based Biomarker Market Share by Country (2020-2031)

Figure 21. United States Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Blood-based Biomarker Market Share by Country (2020-2031)

Figure 25. Germany Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Blood-based Biomarker Market Share by Region (2020-2031)

Figure 33. China Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Blood-based Biomarker Market Share by Country (2020-2031)

Figure 41. Mexico Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Blood-based Biomarker Market Share by Country (2020-2031)

Figure 45. Turkey Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Blood-based Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Diagnostics Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 51. Qiagen Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 53. Siemens Healthineers Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 54. Danaher Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 55. Quidel Corporation Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 56. Grifols Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 57. Biocartis Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 58. Vernalis Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 59. Labcorp Drug Development Revenue Growth Rate in Blood-based Biomarker Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Commercializing Biomarkers Market Research Report 2025

Global Cancer Molecular Biomarkers Market Research Report 2024

Global Clinical Biomarker Testing Market Research Report 2024

Global Clinical Biomarkers Market Research Report 2024

Global Cardiac Biomarkers Testing Market Insights Forecast to 2030

Global Biomarker Detection Systems Market Research Report 2024

Global Diagnostic Biomarker Market Research Report 2024

Global Cancer Biomarker Market Insights Forecast to 2030

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030

Global Biomarker Market Research Report 2024

Global Noninvasive Cancer Biomarkers Market Research Report 2024

Global Digital Biomarker Market Research Report 2025

Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Home Blood Testing Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Blood Products Market Research Report 2025

Global Blood and Blood Components Market Insights Forecast to 2030

Global Brain Biomarker Market Research Report 2024

Global Alzheimer s Disease AD Blood based Detection Kits Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions